Applications of 3',4'-Dimethoxyflavone in Industrial Manufacturing

As a direct manufacturer, we supply 3',4'-Dimethoxyflavone of consistent quality to downstream processors who utilize this specialty flavone in recognized industrial segments. Our material integrates into established production lines where known end-use benefits drive adoption, supporting compliance with respective sector regulations and standards. Detailed below are the primary application scenarios in which our material is effectively incorporated by global industrial clients.

1. Pharmaceutical API Intermediate for Anti-Inflammatory Drug Synthesis

3',4'-Dimethoxyflavone functions as a crucial intermediate in pharmaceutical synthesis, especially for the development of anti-inflammatory and immunomodulatory agents. Its structural alignment supports targeted reactions in active pharmaceutical ingredient (API) elaboration, where downstream manufacturers require high chemical purity and adherence to pharmacopoeial monographs. Commercial integration occurs during multi-step synthesis, bridging raw material input and final bioactive compound release. Formulators adjust concentration according to specific process yields and the requirements of each drug product.

Industry compliance standards

• USP (United States Pharmacopeia) Monographs
• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU GMP Guidelines Part II (APIs)
• China Pharmacopoeia (when applicable for API exportation)

Typical usage ratio

• Batch input levels typically range from 0.8% to 6% w/w, subject to solvent pathways and targeted step conversion yields in the total synthesis sequence

Downstream process integration

• Charged as a reaction intermediate during condensation and methylation steps in the multi-stage API synthesis process; proceeds to further modification or cyclization as defined by the drug master file

Final product types

• Small-molecule anti-inflammatory agents (e.g., non-steroidal pharmaceuticals, immunomodulatory APIs)
• Active intermediates for finished drug substances

2. Biomedical Research Reagent Manufacturing

The compound sees routine use as a research reference standard and biochemical probe within the biomedical sector. Specialist reagent manufacturers incorporate it during the assembly of validated kits and molecular assays that require precise anti-apoptotic and enzyme inhibition profiling. Production follows ISO-certified protocols to ensure traceability and batch-to-batch consistency for downstream quality assurance.

Industry compliance standards

• ISO 13485:2016 Quality Management Systems for Medical Devices and Reagents
• OECD Good Laboratory Practice (GLP) for chemical reagent production
• REACH Registration for laboratory use in Europe

Typical usage ratio

• Formulation concentrations from 10 μM to 500 μM in assay buffer systems; standardized kit dosage varies by the intended cellular assay design

Downstream process integration

• Dissolved into assay solutions or substrates at the analytical formulation stage and subjected to aliquoting for cell culture, enzyme inhibition, or diagnostic use

Final product types

• Research-use-only (RUO) molecular assay kits
• Reference standards for academic and commercial laboratories
• Enzyme and signaling pathway investigation kits

3. Food Additive Applications in Functional Beverage Formulation

In food-processing environments, beverage and nutraceutical producers utilize this material for its natural compound status and documented presence in certain botanical extracts. It provides formulation attributes necessary for product lines targeting anti-oxidant support and polyphenol enrichment. Only facilities operating under established food safety and purity controls can introduce this ingredient at trace levels to satisfy both regulatory and consumer safety demands.

Industry compliance standards

• FDA GRAS (Generally Recognized as Safe) Framework in the United States
• EU Regulation (EC) No 1333/2008 on food additives
• FSSC 22000 Food Safety System Certification for processing sites

Typical usage ratio

• Low-level inclusion, typically 0.003% to 0.02% w/w in concentrate or ready-to-drink beverages; adjusted for local maximum residue limits and sensory assessment

Downstream process integration

• Dosed during liquid blending alongside other polyphenolic ingredients; stability ensured through chelation and pasteurization stages to prevent decomposition

Final product types

• Functional soft drinks and ‘superfood’ beverages
• Enhanced teas and nutraceutical drink blends
• Botanical extract beverages positioned for antioxidant labeling claims

4. Cosmetic Active Ingredient for Anti-Aging Formulations

Manufacturers in the personal care industry employ 3',4'-Dimethoxyflavone during the compounding of cosmetic serums and creams owing to its antioxidant profile and stability. It is selectively incorporated by brands committed to regulatory-compliant, evidence-supported actives. Processing lines apply strict ingredient verification protocols, integrating the compound into oil or aqueous phases for effective anti-aging, brightening, or protective skin formulations.

Industry compliance standards

• EU Regulation (EC) No 1223/2009 on Cosmetic Products
• ASEAN Cosmetic Directive for Southeast Asian markets
• ISO 22716:2007 Cosmetics–Guidelines on Good Manufacturing Practices

Typical usage ratio

• Typical incorporation rate: 0.01% to 0.15% w/w in final cosmetic formulations; concentration fine-tuned according to finished product claim substantiation and safety assessment

Downstream process integration

• Added during the active ingredient blending stage before final emulsification or homogenization steps, ensuring full dispersion for uniform distribution in the finished cosmetic matrix

Final product types

• Anti-aging face serums
• Brightening creams
• Protective day and night lotions marketed with polyphenol content disclosure